Nivo+CT=CheckMate 012
Rizvi NA, et al. JCO 2016
* Most commonly reported (>30%): fatigue, nausea, decreased appetite and alopecia
* Most common G3-4 AEs (>5%): pneumonitis (13%), fatigue, and acute renal failure
* Consider a preliminary 23% of Infusion-related reaction rate